Annual SG&A
$662.47M$34.45M+5.49%
Summary
- Current Value
- As of today, VEEV annual SG&A is $662.47M, up +5.49% on
- Historical Performance
- VEEV annual SG&A is up +44.15% over the past 3 years, and up +117.49% over the past 5 years
- All-Time High Comparison
- VEEV annual SG&A is currently at its all-time high
- 3-Year Low Comparison
- VEEV annual SG&A is +44.15% above its 3-year low of $459.57M reached on an earlier date
- Sector Comparison
- VEEV annual SG&A is higher than 95.69% of companies in Healthcare sector
SG&A Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $662.47M | +5.5% | +44.1% | +117.5% | +8094.8% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $15.14B | +2227.8% | +2686.7% | +3909.6% | +10000.0% | |
| Price | $237.87 | +11.7% | +49.0% | -11.4% | – | |
| Annual Operating Expenses | $1.36B | +7.8% | +61.1% | +163.5% | +10000.0% | |
| Annual Operating Profit | $691.44M | +61.0% | +36.8% | +141.6% | +10000.0% | |
| Annual D&A | $39.38M | +20.7% | +43.5% | +98.3% | +10000.0% | |
| Annual Revenue | $2.75B | +16.2% | +48.4% | +148.8% | +9329.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $662.47M | at high | |
| 5Y | $662.47M | at high | |
| All | $662.47M | at high |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $459.57M | N/A | +44.1% |
| 5Y | $304.60M | N/A | +117.5% |
| All | $8.08M | +8094.8% |
SG&A History
FAQ
What is the current annual SG&A of VEEV?
As of today, VEEV annual SG&A is $662.47M
What is 1-year change in VEEV annual SG&A?
VEEV annual SG&A is up +5.49% year-over-year
What is 3-year change in VEEV annual SG&A?
VEEV annual SG&A is up +44.15% over the past 3 years
How far is VEEV annual SG&A from its all-time high?
VEEV annual SG&A is currently at its all-time high
How does VEEV annual SG&A rank versus sector peers?
VEEV annual SG&A is higher than 95.69% of companies in Healthcare sector
When is VEEV next annual earnings release?
The next annual earnings release for VEEV is on
Quarterly SG&A
$0.00$205.24M-100.00%
Summary
- Current Value
- As of today, VEEV quarterly SG&A is $0.00, down -100.00% on
- Historical Performance
- VEEV quarterly SG&A is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- VEEV quarterly SG&A is currently -100.00% below its historical high of $205.24M set on
- 3-Year Low Comparison
- VEEV quarterly SG&A vs 3-year low value is unknown
- Sector Comparison
- VEEV quarterly SG&A is higher than 45.54% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual SG&A | $662.47M | – | +5.5% | +44.1% | +117.5% | |
| TTM SG&A | $15.14B | +2021.3% | +2227.8% | +2686.7% | +3909.6% | |
| Price | $237.87 | -20.6% | +11.7% | +49.0% | -11.4% | |
| Quarterly Operating Expenses | $372.10M | +2.1% | +8.3% | +34.3% | +114.8% | |
| Quarterly Operating Profit | $240.85M | +6.3% | +32.8% | +98.4% | +137.8% | |
| Quarterly D&A | $12.80M | -2.9% | +0.2% | +24.8% | +18.0% | |
| Quarterly Revenue | $811.24M | +2.8% | +16.0% | +46.9% | +114.9% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $205.24M | -100.0% | |
| 3Y | $205.24M | -100.0% | |
| 5Y | $205.24M | -100.0% | |
| All | $205.24M | -100.0% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of VEEV?
As of today, VEEV quarterly SG&A is $0.00
What is VEEV quarterly SG&A most recent change?
VEEV quarterly SG&A was down -100.00% on October 31, 2025
What is 1-year change in VEEV quarterly SG&A?
VEEV quarterly SG&A is down -100.00% year-over-year
How far is VEEV quarterly SG&A from its all-time high?
VEEV quarterly SG&A is currently -100.00% below its historical high of $205.24M set on July 31, 2025
How does VEEV quarterly SG&A rank versus sector peers?
VEEV quarterly SG&A is higher than 45.54% of companies in Healthcare sector
When is VEEV next earnings release?
The next earnings release for VEEV is on
TTM SG&A
$15.14B$860.33M+6.02%
Summary
- Current Value
- As of today, VEEV TTM SG&A is $15.14B, up +6.02% on
- Historical Performance
- VEEV TTM SG&A is up +2227.81% year-over-year, and up +2686.65% over the past 3 years
- All-Time High Comparison
- VEEV TTM SG&A is currently at its all-time high
- 3-Year Low Comparison
- VEEV TTM SG&A is +101.91% above its 3-year low of $7.50B reached on an earlier date
- Sector Comparison
- VEEV TTM SG&A is higher than 95.49% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $15.14B | +2021.3% | +2227.8% | +2686.7% | +3909.6% | |
| Annual SG&A | $662.47M | – | +5.5% | +44.1% | +117.5% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $237.87 | -20.6% | +11.7% | +49.0% | -11.4% | |
| TTM Operating Profit | $889.54M | +7.2% | +39.4% | +89.3% | +162.1% | |
| TTM D&A | $52.19M | +0.0% | +6.0% | +29.1% | +20.5% | |
| TTM Revenue | $3.08B | +3.8% | +16.0% | +48.3% | +123.2% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $15.14B | N/A | at high |
| 3Y | $15.14B | N/A | at high |
| 5Y | $15.14B | N/A | at high |
| All | $15.14B | N/A | at high |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $11.97B | N/A | +26.4% |
| 3Y | $7.50B | N/A | +101.9% |
| 5Y | $4.22B | N/A | +258.6% |
| All | $24.93M | N/A | >+9999.0% |
TTM SG&A History
FAQ
What is the current TTM SG&A of VEEV?
As of today, VEEV TTM SG&A is $15.14B
What is VEEV TTM SG&A most recent change?
VEEV TTM SG&A was up +6.02% on October 31, 2025
What is 1-year change in VEEV TTM SG&A?
VEEV TTM SG&A is up +2227.81% year-over-year
How far is VEEV TTM SG&A from its all-time high?
VEEV TTM SG&A is currently at its all-time high
How does VEEV TTM SG&A rank versus sector peers?
VEEV TTM SG&A is higher than 95.49% of companies in Healthcare sector
When is VEEV next earnings release?
The next earnings release for VEEV is on
Selling, General & Administrative Expenses Formula
SG&A = − − R&D
Data Sources & References
- VEEV Official Website www.veeva.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1393052/000139305225000078/0001393052-25-000078-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1393052/000139305225000022/0001393052-25-000022-index.htm
- VEEV Profile on Yahoo Finance finance.yahoo.com/quote/VEEV
- VEEV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/veev